,i  #aaf? ,,congress  #b;d ,session  ,h4
 ,r4 #fgja  ,,9 ,,! ,,h\se ,,(          
,,repres5tatives  ,may #e1 #bjbj,ms4    
,e%oo 7= h]self1 ,mr4 ,burgess1 ,ms4    
,de,gette1 & ,mr4 ,gu?rie7 introduc$ !  
foll[+ bill2 :i* 0 ref]r$ to !          
,committee on ,en]gy & ,comm]ce  ,a     
,,bill  ,to require a longitud9al /udy  
on ! impact ( ,,covid-#ai4  #a4 ,%ort   
title ,?is ,act may be cit$ z ! ,ensur+ 
,und]/&+ ( ,,covid-#ai to ,protect      
,public ,heal? ,act4  #b4 ,/udy on !    
impact ( ,,covid-#ai ,"p ,a ( title ,,iv
 ( ! ,public ,heal? ,s]vice ,act 7#db   
,u4,s4,c4 #bha et seq47 is am5d$ by add+
 at ! end ! foll[+3  #djd,o4 ,/udy on ! 
impact ( ,,covid-#ai  7a7 ,9 g5]al ,!   
,director ( ,,nih1 9 consultation ) !   
,director ( ! ,c5t]s = ,disease ,control
 & ,prev5tion1 %all conduct a           
longitud9al /udy1 ov] n less ?an #aj    
ye>s1 on ! full impact ( ,,covid-#ai on 
infect$ individuals1 includ+ bo?        
%ort-t]m & long-t]m heal? impacts4  7b7 
,tim+ ,! ,director ( ,,nih %all beg9    

enroll+ pati5ts 9 ! /udy "u ?is section 
n lat] ?an #f mon?s aft] ! date (       
enactm5t ( ?is section4  7c7            
,requirem5ts ,! /udy "u ?is section     
%all-- 7#a7 be nationwide2  7#b7 include
 div]sity ( enrollees to acc\nt = g5d]1 
age1 race1 e?nicity1 geography1         
comorbidities1 & und]repres5t$          
populations1 includ+ pregnant & lactat+ 
wom52  7#c7 /udy individuals :o 7       
infect$ ) ,,covid-#ai :o exp]i5c$ mild  
symptoms1 su* individuals :o exp]i5c$   
mod]ate symptoms1 & su* individuals :o  
exp]i5c$ sev]e symptoms2  7#d7 monitor !
 heal? outcomes & symptoms ( individuals
 :o 7 infect$ ) ,,covid-#ai1 or _h      
pr5atal exposure to ,,covid-#ai1 includ+
 lung capacity & function1 & immune     
response1 tak+ into acc\nt any          
ph>maceutical int]v5tions su*           
individuals may h receiv$2  7#e7 monitor
 ! m5tal heal? outcomes ( individuals   
infect$ ) ,,covid-#ai1 tak+ into acc\nt 
any int]v5tions t affect$ m5tal heal?2 &
  7#f7 monitor individuals enroll$ 9 !  

/udy n less frequ5tly t twice p] ye>    
aft] ! fir/ ye> ( ! individual's        
infection ) ,,covid-#ai4  7d7           
,public-,private rese>* network ,=      
purposes ( c>ry+ out ! /udy "u ?is      
section1 ! ,director ( ,,nih may develop
 a network ( public-private rese>*      
p>tn]s1 provid$ t all rese>*1 includ+ ! 
rese>* c>ri$ out ?r\gh any su* p>tn]1 is
 available publicly4  7e7 ,summ>ies (   
f9d+s ,! ,director ( ,,nih %all make    
public a summ>y ( f9d+s "u ?is section n
 less frequ5tly ?an once e #c mon?s = ! 
fir/ #b ye>s ( ! /udy1 & n less         
frequ5tly ?an e #f mon?s !reaft]4 ,su*  
summ>ies may include in=mation ab\t h[ !
 f9d+s ( ! /udy "u ?is section comp>e ) 
f9d+s f rese>* conduct$ abroad4  7f7    
,au?orization ( appropriations ,!re are 
au?oriz$ to be appropriat$ su* sums z   
may be necess>y to c>ry out ?is section4
  4